Literature DB >> 31659155

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.

Cesarina Giallongo1, Daniele Tibullo2,3, Giuseppina Camiolo4, Nunziatina L Parrinello1, Alessandra Romano1, Fabrizio Puglisi1, Alessandro Barbato1, Concetta Conticello1, Gabriella Lupo4, Carmelina Daniela Anfuso4, Giacomo Lazzarino5, Giovanni Li Volti6,7, Giuseppe Alberto Palumbo8, Francesco Di Raimono1.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2019        PMID： 31659155      PMCID： PMC6817876          DOI： 10.1038/s41419-019-2059-2

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


Correction to: Cell Death and Disease 10.1038/s41419-019-1959-5; published online 20 September 2019 Following publication of this article, it was noted that Francesco Di Raimondo’s name had been listed incorrectly as “Francesco Di Raimono”. This has been corrected in the both the PDF and HTML versions of the Article.
  2 in total

Review 1.  Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects.

Authors:  Armel H Nwabo Kamdje; Paul F Seke Etet; Richard Tagne Simo; Lorella Vecchio; Kiven Erique Lukong; Mauro Krampera
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

2.  Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth.

Authors:  Léa Lemaitre; Malik Hamaidia; Jean-Gérard Descamps; Laura Do Souto Ferreira; Marie-Véronique Joubert; Mélanie Gadelorge; Hervé Avet-Loiseau; Arthur Justo; Nicolas Reina; Frederic Deschaseaux; Ludovic Martinet; Philippe Bourin; Jill Corre; Nicolas Espagnolle
Journal:  Blood Adv       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.